Clearside Biomedical Inc. (CLSD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
4.04
0.31 (8.31%)
At close: Sep 26, 2025, 3:59 PM
4.06
0.50%
After-hours: Sep 26, 2025, 07:42 PM EDT

Clearside Biomedical Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.04 -2.23 -2.05 427.80
PEG Ratio
0.18 0.61 0.00 -4.21
PS Ratio
42.14 8.79 50.81 5.44
PB Ratio
-1.8 -4.54 6.36 4.24
P/FCF Ratio
-2.73 -3.63 -4.95 -14.99
P/OCF Ratio
-2.84 -3.99 -5.05 -14.99
OCF/S Ratio
-14.84 -2.2 -10.07 -0.36
Debt / Equity Ratio
-1.35 -2.7 3.32 0.02
Quick Ratio
4.44 4.42 8.54 8.88
Current Ratio
4.44 4.42 8.54 9.08
Asset Turnover
0.07 0.24 0.03 0.69
Interest Coverage
-2.95 -2.65 -9.07 n/a
Return on Equity
0.88 2.04 -3.11 0.01
Return on Assets
-1.37 -0.95 -0.64 0.01
Return on Invested Capital
-1.39 -0.89 -0.64 -0.02
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.91 0.96 0.85 1.00
Net Profit Margin
-20.64 -3.95 -24.83 0.01
Pretax Profit Margin
-20.64 -3.95 -24.83 0.01
Operating Profit Margin
-17.36 -3.02 -22.82 -0.02
FCF Margin
-15.43 -2.42 -10.26 -0.36
EBITDA Margin
-14.63 -2.8 -22.2 0.02